common.study.topics.clinical

Ketamine and Fentanyl to Treat Moderate to Severe Pain

common.study.values.description

Sub-Dissociative Ketamine and Fentanyl to Treat Moderate to Severe Pain

The objective of this study is to evaluate the potential opioid-sparing effect associated with the novel combination of fentanyl and sub-dissociative ketamine in adult patients with moderate to severe pain in the emergency department.

common.study.values.location

participant.ui.study.affiliations-map.online-study.header-virtual

participant.ui.study.affiliations-map.online-study.text

participant.ui.study.affiliations-map.legend.locations participant.ui.study.affiliations-map.legend.selected

common.study.values.methods

Pharmaceutical medication involved common.study.methods.has-drugs-yes
Patients and healthy individuals accepted common.study.methods.is-healthy-no

Drug - Fentanyl

1 mg/kg of Fentanyl IV administered over at least 1 minute

Combination Product - Fentanyl and Ketamine

Combined dose of 0.15 mg/kg of Sub-dissociative Ketamine and 0.5 mg/kg of Fentanyl IV administered over at least 1 minute.

Drug - Ketamine

0.3 mg/kg of Sub-Dissociative Ketamine IV administered over at least 1 minute

participant.views.study.view.additional

participant.views.study.view.scientific-title

A Combination Study With Sub-Dissociative Ketamine and Fentanyl to Treat Moderate to Severe Pain in the Emergency Department

common.study.values.clinical-trial-id

NCT03959852

participant.views.study.view.id

bqxn7a